Oruka Therapeutics, Inc. Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
Oruka Therapeutics, Inc. (ORKA) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 9.77 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2026-08-10
- Oruka Therapeutics, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-06-30 was 9.77M shares, a 10.82% increase year-over-year.
- Oruka Therapeutics, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-03-31 was 10.46M shares, a 22.33% increase year-over-year.
- Oruka Therapeutics, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-09-30 was 8.82M shares, a 34.68% increase year-over-year.
- Oruka Therapeutics, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-06-30 was 8.81M shares, a 40.51% decline year-over-year.
- Oruka Therapeutics, Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2025 was 9.10M shares.
- Oruka Therapeutics, Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2023 was 616.71K shares, a 22.52% decline from fiscal 2022.
- Oruka Therapeutics, Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2022 was 795.96K shares, a 23.28% decline from fiscal 2021.
- Oruka Therapeutics, Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2021 was 1.04M shares, a 56.10% increase from fiscal 2020.
| Period end | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 2 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 5 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 8 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 11 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month as first filed |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 9.77M shares 10-Q · filed 2026-08-10 | 9.77M shares 10-Q · filed 2026-08-10 | ||||||||||
| 2026-03-31 | 10.46M shares 10-Q · filed 2026-05-13 | |||||||||||
| 2025-12-31 | 9.10M shares 10-K · filed 2026-03-12 | |||||||||||
| 2025-09-30 | 8.82M shares 10-Q · filed 2025-11-12 | 8.82M shares 10-Q · filed 2025-11-12 | ||||||||||
| 2025-06-30 | 8.81M shares 10-Q · filed 2026-08-10 | 8.81M shares 10-Q · filed 2026-08-10 | ||||||||||
| 2025-03-31 | 8.55M shares 10-Q · filed 2026-05-13 | |||||||||||
| 2024-12-31 | 7.43M shares 10-K · filed 2026-03-12 | |||||||||||
| 2024-09-30 | 6.55M shares 10-Q · filed 2025-11-12 | 6.55M shares 10-Q · filed 2025-11-12 | ||||||||||
| 2024-06-30 | 14.81M shares 10-Q · filed 2025-08-11 | 607.05K shares 10-Q · filed 2024-08-01 | 14.81M shares 10-Q · filed 2025-08-11 | 607.05K shares 10-Q · filed 2024-08-01 | ||||||||
| 2024-03-31 | 2.61M shares 10-Q · filed 2025-05-14 | 645.85K shares 10-Q · filed 2024-04-25 | ||||||||||
| 2023-12-31 | 616.71K shares 10-K · filed 2024-02-01 | |||||||||||
| 2023-09-30 | 707.79K shares 10-Q · filed 2023-10-18 | 707.79K shares 10-Q · filed 2023-10-18 | ||||||||||
| 2023-06-30 | 710.78K shares 10-Q · filed 2024-08-01 | 710.78K shares 10-Q · filed 2024-08-01 | ||||||||||
| 2023-03-31 | 755.86K shares 10-Q · filed 2024-04-25 | |||||||||||
| 2022-12-31 | 795.96K shares 10-K · filed 2024-02-01 | |||||||||||
| 2022-09-30 | 729.23K shares 10-Q · filed 2023-10-18 | 729.23K shares 10-Q · filed 2023-10-18 | ||||||||||
| 2022-06-30 | 880.51K shares 10-Q · filed 2023-07-21 | 880.51K shares 10-Q · filed 2023-07-21 | ||||||||||
| 2022-03-31 | 1.00M shares 10-Q · filed 2023-04-24 | |||||||||||
| 2021-12-31 | 1.04M shares 10-K · filed 2023-02-24 | |||||||||||
| 2021-09-30 | 774.02K shares 10-Q · filed 2022-10-28 | |||||||||||
| 2021-06-30 | 758.30K shares 10-Q · filed 2022-08-02 | |||||||||||
| 2021-03-31 | 729.90K shares 10-Q · filed 2022-05-02 | |||||||||||
| 2020-12-31 | 664.64K shares 10-K · filed 2022-03-14 | |||||||||||
| 2020-09-30 | 170.54K shares 10-Q · filed 2020-11-02 | 170.54K shares 10-Q · filed 2021-11-02 | ||||||||||
| 2020-06-30 | 164.29K shares 10-Q · filed 2020-08-05 | 164.29K shares 10-Q · filed 2021-08-04 | ||||||||||
| 2020-03-31 | 164.29K shares 10-Q · filed 2021-05-11 | |||||||||||
| 2019-12-31 | 167.00K shares 10-K · filed 2021-03-18 | |||||||||||
| 2019-09-30 | 168.54K shares 10-Q · filed 2020-11-02 | 168.54K shares 10-Q · filed 2020-11-02 | ||||||||||
| 2019-06-30 | 168.69K shares 10-Q · filed 2020-08-05 | 168.69K shares 10-Q · filed 2020-08-05 | ||||||||||
| 2019-03-31 | 169.14K shares 10-Q · filed 2020-05-06 | |||||||||||
| 2018-12-31 | 181.83K shares 10-K · filed 2020-02-18 | 3.27M shares 10-K · filed 2019-02-27 | ||||||||||
| 2018-09-30 | 181.86K shares 10-Q · filed 2019-11-06 | 3.27M shares 10-Q · filed 2018-11-14 | ||||||||||
| 2018-06-30 | 183.03K shares 10-Q · filed 2019-08-01 | 3.30M shares 10-Q · filed 2018-08-09 | ||||||||||
| 2018-03-31 | 237.46K shares 10-Q · filed 2019-05-08 | 4.28M shares 10-Q · filed 2018-05-08 | ||||||||||
| 2017-12-31 | 4.26M shares 10-K · filed 2019-02-27 | |||||||||||
| 2017-09-30 | 4.49M shares 10-Q · filed 2018-11-14 | |||||||||||
| 2017-06-30 | 4.49M shares 10-Q · filed 2018-08-09 | |||||||||||
| 2017-03-31 | 4.54M shares 10-Q · filed 2018-05-08 | |||||||||||
| 2016-12-31 | 4.35M shares 10-K · filed 2018-03-22 | |||||||||||
| 2016-09-30 | 4.34M shares 10-Q · filed 2017-11-09 | |||||||||||
| 2016-06-30 | 4.35M shares 10-Q · filed 2017-08-03 | |||||||||||
| 2016-03-31 | 3.97M shares 10-Q · filed 2017-05-15 | |||||||||||
| 2015-12-31 | 3.96M shares 10-K · filed 2017-03-21 | |||||||||||
| 2015-09-30 | 3.98M shares 10-Q · filed 2016-11-14 | |||||||||||
| 2015-06-30 | 4.00M shares 10-Q · filed 2016-08-09 | 28.01M shares 10-Q · filed 2015-08-11 | ||||||||||
| 2015-03-31 | 1.60M shares 10-Q · filed 2016-05-11 | 11.19M shares 10-Q · filed 2015-05-12 | ||||||||||
| 2014-12-31 | 1.56M shares 10-K · filed 2016-03-17 | 10.91M shares 10-K · filed 2015-03-19 | ||||||||||
| 2014-09-30 | 10.90M shares 10-Q · filed 2014-11-12 | 1.56M shares 10-Q · filed 2015-11-12 | 10.60M shares 10-Q · filed 2014-11-12 | |||||||||
| 2014-06-30 | 11.00M shares 10-Q · filed 2014-08-13 | 11.02M shares 10-Q · filed 2015-08-11 | 10.60M shares 10-Q · filed 2014-08-13 | |||||||||
| 2014-03-31 | 11.03M shares 10-Q · filed 2015-05-12 | 10.20M shares 10-Q · filed 2014-05-13 | ||||||||||
| 2013-12-31 | 9.41M shares 10-K · filed 2015-03-19 | 7.37M shares 10-K · filed 2014-03-20 | ||||||||||
| 2013-09-30 | 13.10M shares 10-Q · filed 2014-11-12 | 6.70M shares 10-Q · filed 2014-11-12 | ||||||||||
| 2013-06-30 | 5.20M shares 10-Q · filed 2014-08-13 | 3.30M shares 10-Q · filed 2014-08-13 | ||||||||||
| 2013-03-31 | 1.30M shares 10-Q · filed 2014-05-13 | |||||||||||
| 2012-12-31 | 762.00K shares 10-K · filed 2014-03-20 | |||||||||||
| 2012-09-30 | 800.00K shares 10-Q · filed 2013-11-13 | 700.00K shares 10-Q · filed 2013-11-13 | ||||||||||
| 2012-06-30 | 606.00K shares 10-Q · filed 2013-08-13 | 605.00K shares 10-Q · filed 2013-08-13 | ||||||||||
| 2012-03-31 | 604.00K shares 10-Q · filed 2013-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |
| Dianthus Therapeutics, Inc. /DE/ (DNTH) | United States | $5.082B | -27.79 |
| Erasca, Inc. (ERAS) | United States | $5.073B | -19.96 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Veradermics, Inc (MANE) | United States | $4.839B |